Senolytics to Improve Osteoporosis Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 6, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Osteopenia, Osteoporosis
Interventions
DRUG

Dasatinib 100 Mg Oral Tablet

"Dasatinib tablets in blister packs of 10 tablets, from either: Sandoz, STADA Nordic, Zentiva or Bristol-Myers Squibb"

DIETARY_SUPPLEMENT

Quercetin 1.250 mg (oral)

five 200mg Quercetin Phytosome capsules, from Thorne

DIETARY_SUPPLEMENT

Nicotinamide Riboside 1g (oral)

four 250mg Nicotinamide Riboside Capsules, from Elysium Health

Trial Locations (1)

5000

RECRUITING

Odense University Hospital, Odense

All Listed Sponsors
collaborator

Odense Patient Data Explorative Network

OTHER

collaborator

The Novo Nordisk Foundation Center for Basic Metabolic Research

OTHER

lead

Odense University Hospital

OTHER